Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.27
+0.08 (1.54%)
Nov 22, 2024, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$7.60
Upside
+44.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold → Buy Upgrades $3 → $11 | Hold → Buy | Upgrades | $3 → $11 | +108.73% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +127.70% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +51.80% | Oct 18, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | -24.10% | Jul 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +51.80% | Jul 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +51.80% | Jun 24, 2024 |
| Mizuho | Mizuho | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | -43.07% | May 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +51.80% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +51.80% | Apr 11, 2024 |
| Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | -43.07% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +51.80% | Apr 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $8 | Strong Buy | Maintains | $42 → $8 | +51.80% | Mar 12, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $36 → $8 | Strong Buy | Maintains | $36 → $8 | +51.80% | Mar 11, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $40 → $4 | Strong Buy → Hold | Downgrades | $40 → $4 | -24.10% | Mar 11, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 11, 2024 |
| Baird | Baird | Buy → Hold Downgrades $37 → $4 | Buy → Hold | Downgrades | $37 → $4 | -24.10% | Mar 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.